IL10 Secretion Endows Intestinal Human iNKT Cells with Regulatory Functions Towards Pathogenic T Lymphocytes.
Crohn’s disease
IL10
SCFA
iNKT cells
microbiota
Journal
Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676
Informations de publication
Date de publication:
08 Sep 2022
08 Sep 2022
Historique:
pubmed:
1
4
2022
medline:
14
9
2022
entrez:
31
3
2022
Statut:
ppublish
Résumé
Invariant natural killer T [iNKT] cells perform pleiotropic functions in different tissues by secreting a vast array of pro-inflammatory and cytotoxic molecules. However, the presence and function of human intestinal iNKT cells capable of secreting immunomodulatory molecules such as IL-10 has never been reported so far. Here we describe for the first time the presence of IL10-producing iNKT cells [NKT10 cells] in the intestinal lamina propria of healthy individuals and of Crohn's disease [CD] patients. Frequency and phenotype of NKT10 cells were analysed ex vivo from intestinal specimens of Crohn's disease [n = 17] and controls [n = 7]. Stable CD-derived intestinal NKT10 cell lines were used to perform in vitro suppression assays and co-cultures with patient-derived mucosa-associated microbiota. Experimental colitis models were performed by adoptive cell transfer of splenic naïve CD4+ T cells in the presence or absence of IL10-sufficient or -deficient iNKT cells. In vivo induction of NKT10 cells was performed by administration of short chain fatty acids [SCFA] by oral gavage. Patient-derived intestinal NKT10 cells demonstrated suppressive capabilities towards pathogenic CD4+ T cells. The presence of increased proportions of mucosal NKT10 cells associated with better clinical outcomes in CD patients. Moreover, an intestinal microbial community enriched in SCFA-producing bacteria sustained the production of IL10 by iNKT cells. Finally, IL10-deficient iNKT cells failed to control the pathogenic activity of adoptively transferred CD4+ T cells in an experimental colitis model. These results describe an unprecedentd IL10-mediated immunoregulatory role of intestinal iNKT cells in controlling the pathogenic functions of mucosal T helper subsets and in maintaining the intestinal immune homeostasis.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
Invariant natural killer T [iNKT] cells perform pleiotropic functions in different tissues by secreting a vast array of pro-inflammatory and cytotoxic molecules. However, the presence and function of human intestinal iNKT cells capable of secreting immunomodulatory molecules such as IL-10 has never been reported so far. Here we describe for the first time the presence of IL10-producing iNKT cells [NKT10 cells] in the intestinal lamina propria of healthy individuals and of Crohn's disease [CD] patients.
METHODS
METHODS
Frequency and phenotype of NKT10 cells were analysed ex vivo from intestinal specimens of Crohn's disease [n = 17] and controls [n = 7]. Stable CD-derived intestinal NKT10 cell lines were used to perform in vitro suppression assays and co-cultures with patient-derived mucosa-associated microbiota. Experimental colitis models were performed by adoptive cell transfer of splenic naïve CD4+ T cells in the presence or absence of IL10-sufficient or -deficient iNKT cells. In vivo induction of NKT10 cells was performed by administration of short chain fatty acids [SCFA] by oral gavage.
RESULTS
RESULTS
Patient-derived intestinal NKT10 cells demonstrated suppressive capabilities towards pathogenic CD4+ T cells. The presence of increased proportions of mucosal NKT10 cells associated with better clinical outcomes in CD patients. Moreover, an intestinal microbial community enriched in SCFA-producing bacteria sustained the production of IL10 by iNKT cells. Finally, IL10-deficient iNKT cells failed to control the pathogenic activity of adoptively transferred CD4+ T cells in an experimental colitis model.
CONCLUSIONS
CONCLUSIONS
These results describe an unprecedentd IL10-mediated immunoregulatory role of intestinal iNKT cells in controlling the pathogenic functions of mucosal T helper subsets and in maintaining the intestinal immune homeostasis.
Identifiants
pubmed: 35358301
pii: 6561819
doi: 10.1093/ecco-jcc/jjac049
pmc: PMC9455792
doi:
Substances chimiques
IL10 protein, human
0
Interleukin-10
130068-27-8
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1461-1474Subventions
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : 14378
Organisme : Italy's Ministry of Health
ID : GR-2016-0236174
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation.
Références
Immunity. 2008 Apr;28(4):546-58
pubmed: 18387831
Front Med (Lausanne). 2018 Feb 07;5:21
pubmed: 29468162
J Allergy Clin Immunol. 2018 Nov;142(5):1537-1547.e8
pubmed: 29369775
J Immunol. 2008 Jul 15;181(2):869-77
pubmed: 18606638
J Immunol. 2011 Jun 15;186(12):6815-21
pubmed: 21572032
Nat Rev Immunol. 2018 Sep;18(9):559-574
pubmed: 29967365
Annu Rev Immunol. 2010;28:573-621
pubmed: 20192811
Sci Rep. 2015 May 19;5:9743
pubmed: 25988396
Nat Immunol. 2012 Mar 18;13(5):474-80
pubmed: 22426352
J Immunol. 2008 Feb 1;180(3):1800-7
pubmed: 18209077
J Crohns Colitis. 2020 Sep 16;14(9):1190-1201
pubmed: 32100016
Immunity. 2015 Sep 15;43(3):566-78
pubmed: 26362265
J Allergy Clin Immunol. 2016 Jan;137(1):318-321.e5
pubmed: 26318071
Int Immunol. 1993 Nov;5(11):1461-71
pubmed: 7903159
Front Immunol. 2018 Mar 13;9:519
pubmed: 29593743
Nature. 2014 May 22;509(7501):497-502
pubmed: 24717441
J Exp Med. 1998 Jul 20;188(2):287-96
pubmed: 9670041
Microbiome. 2021 Feb 6;9(1):39
pubmed: 33549144
Immunity. 2002 Nov;17(5):629-38
pubmed: 12433369
Life Sci Alliance. 2019 Feb 13;2(1):
pubmed: 30760554
Nat Immunol. 2013 Nov;14(11):1146-54
pubmed: 24097110
Immunity. 2012 Sep 21;37(3):574-87
pubmed: 22981538
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Clin Invest. 2004 May;113(10):1490-7
pubmed: 15146247
Gastroenterology. 2005 Jun;128(7):1868-78
pubmed: 15940622
Annu Rev Immunol. 2007;25:297-336
pubmed: 17150027
J Vis Exp. 2019 Jan 7;(143):
pubmed: 30663692
Front Immunol. 2018 Jan 10;8:1945
pubmed: 29375569
J Exp Med. 1998 Dec 21;188(12):2205-13
pubmed: 9858507
Cells. 2019 May 28;8(6):
pubmed: 31142049
J Exp Med. 2008 Oct 27;205(11):2483-90
pubmed: 18852290
N Engl J Med. 2006 Mar 2;354(9):942-55
pubmed: 16510748
Appl Environ Microbiol. 2006 Jul;72(7):5069-72
pubmed: 16820507
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
pubmed: 17586664
Nat Immunol. 2015 Jan;16(1):85-95
pubmed: 25436972
Inflamm Bowel Dis. 2006 Jun;12(6):447-56
pubmed: 16775488
Mucosal Immunol. 2009 Sep;2(5):393-402
pubmed: 19587641
Cells. 2020 May 16;9(5):
pubmed: 32429359
Nat Immunol. 2011 May;12(5):450-9
pubmed: 21460847
Gastroenterology. 2019 Dec;157(6):1584-1598
pubmed: 31513797
Adv Immunol. 2014;122:177-210
pubmed: 24507158
Trends Microbiol. 2021 Aug;29(8):700-712
pubmed: 33674141
Cell. 2014 Jan 16;156(1-2):123-33
pubmed: 24439373
Swiss Med Wkly. 2018 Sep 23;148:w14671
pubmed: 30378641
Gastroenterology. 2012 Aug;143(2):418-28
pubmed: 22522092
Nat Commun. 2018 Dec 5;9(1):5184
pubmed: 30518790
Nat Med. 2013 Jun;19(6):739-46
pubmed: 23624599
J Clin Invest. 2014 Sep;124(9):3725-40
pubmed: 25061873
Annu Rev Immunol. 2016 May 20;34:479-510
pubmed: 26927205
J Leukoc Biol. 2009 Oct;86(4):757-68
pubmed: 19465641
Gastroenterology. 2016 Dec;151(6):1100-1104
pubmed: 27693323
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Inflamm Bowel Dis. 2017 Nov;23(11):1950-1961
pubmed: 29023267
Immunobiology. 2015 Aug;220(8):1025-9
pubmed: 25770018
Front Immunol. 2015 Aug 04;6:400
pubmed: 26300885
Cell. 2016 Jun 2;165(6):1332-1345
pubmed: 27259147
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W394-9
pubmed: 16845035
Immunity. 2011 Apr 22;34(4):554-65
pubmed: 21511184
Eur J Immunol. 2014 Feb;44(2):370-85
pubmed: 24338958
PLoS Comput Biol. 2014 Apr 03;10(4):e1003531
pubmed: 24699258
Cytokine Growth Factor Rev. 2016 Aug;30:87-93
pubmed: 26980675
Front Immunol. 2018 Sep 11;9:2082
pubmed: 30254647
Nat Rev Microbiol. 2007 Jun;5(6):405-17
pubmed: 17487145
Front Immunol. 2018 Aug 15;9:1838
pubmed: 30158927
Cell Mol Gastroenterol Hepatol. 2016 May;2(3):274-280
pubmed: 27570813
Cell Rep. 2018 Mar 13;22(11):3006-3020
pubmed: 29539427